Racial disparities in prostate
cancer epidemiology and survival outcomes generally have been well documented,
with assorted facts and figures indicating that African-American men are disadvantaged
with regard to disease control and therapeutic gains associated with this
disease relative to their Caucasian-American counterparts.
Prostate cancer is a daunting
disease state for all Americans it represents the most commonly diagnosed
malignancy and the second most common cause of cancer-related deaths in the
United States. However, for African-American men, the public health
implications of this disease are all the more sobering: the disease incidence
is 1.62-fold greater for African-American men than for Caucasian-American men
and the mortality rate-ratio is 2.45-fold greater, respectively.
In blunt absolute terms, 1 in 3
African-American men will be at risk for developing clinically significant
prostate cancer and as much as 1 in 5 African-American men >50 years of age
will die of this disease.
No comments:
Post a Comment